BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-904@pharmaconomics
DTSTAMP:20260707T033835Z
DTSTART;VALUE=DATE:20260610
DTEND;VALUE=DATE:20260611
SUMMARY:RFL Phase 3 — Trappsol Cyclo
DESCRIPTION:Phase 3 trial results for Trappsol Cyclo in Niemann-Pick Disease Type C are due Jun 10\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1713863/000121390026067083/ea029415101ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/904
URL:https://pharmaconomics.com/e/904
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:RFL catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR